INFECTION, vol.42, no.1, pp.37-42, 2014 (SCI-Expanded)
To compare clinical and microbiological efficacy of colistin and colistin/sulbactam for the treatment of multidrug-resistant (MDR) Acinetobacter baumannii VAP in intensive care units (ICUs).